Principal component analysis (PCA) of gene expression profiles revealed a main cluster comprising most of the AML cell lines and including both MLL-r and non-MLL-r cells (Figure 4A), thus indicating that treatment with Pinometostat did not induce high variation. The gene discussed is KMT2A; the disease is acute myeloid leukemia.